Oral exposure to the secretions of Rhinella marina (formerly Bufo marinus) can carry a high fatality rate without early and appropriate treatment. In dogs, the clinical syndrome, which is evident almost immediately, manifests in profuse ptyalism along with gastrointestinal, respiratory, and neurologic signs. Severe cardiac arrhythmias develop less frequently. This review will cover the history, toxicology, and clinical syndrome of Rhinella marina intoxication, and will discuss the recommended therapies for stabilization. (J Am Anim Hosp Assoc 2016; 52:205-211.
Introduction
For centuries, toads have been known to carry toxic substances in their skin that serve as a form of chemical defense against predators. 1 Of particular concern in small animal emergency medicine, especially in areas of temperate climate, are the toxic secretions from toads of the family Bufonidae. Bufo marinus, now renamed Rhinella marina, is known to secrete a protective substance that is highly toxic to dogs. 2, 3 While cats can be poisoned by toads, this is not a commonly encountered clinical scenario. 4 Regardless of the species exposed, because the intoxication can lead to seizures and cardiac dysrhythmias, it can be fatal if severe signs develop and are not treated in a timely fashion. 2, 3 However, there is little information on stabilization and treatment required in severe cases of intoxication, especially from an emergency and critical care perspective. This review will cover the history, toxicology, and clinical syndrome of R. marina intoxication with an emphasis on recommended therapies for stabilization and treatment specific for this toxicosis.
History of Rhinella marina
The native range of R. marina extends from South and Central America, throughout Mexico, to southern Texas. R. marina was widely introduced throughout the Caribbean and Pacific Ocean, including Hawaii and Australia in the 1930s, in an effort to control insect pests on sugar cane and other crops. 3-5 R. marina is also found in southern Florida, with the current population originating from an accidental release by an animal importer in Miami prior to 1955 and subsequent, intentional releases by exotic animal dealers in the early 1960s. 6 The habitat of R. marina is not confined to lush tropical or rural areas; in southern Florida, R. marina appears to be thriving in many urban areas and is expected to expand its range further north.
Bufadienolides
Bufadienolides, or bufagins, are structurally similar to cardiac glycosides and comprise at least 8% of the content of the dried secretions in R. marina, with marinobufagenin (also called marinobufagin) being the most common. 16, 17 The chemicallyrelated bufotoxins are also found in the secretions but are less potent than bufadienolides. 1, 12 Despite being relatively lipophilic, bufadienolides are reported to be poorly absorbed from the gastrointestinal (GI) tract of dogs and cats. 1, 18 What is absorbed across the GI mucosa peaks in the circulation within 30 min, and is then fairly quickly eliminated, with half-lives of 2-4 hr being reported in a rodent model, the only species in which the toxicokinetics of bufadienolides have been reported. 19 Bufadienolides cross the blood-brain barrier and can inhibit their own Pglycoprotein-mediated efflux, which the authors speculate serves to concentrate these compounds in tissues including the central nervous system (CNS). 20, 21 One question that has not been well addressed by prior studies is the extent to which absorption of bufadienolides occurs across the oral mucous membranes, which is arguably the region of the GI tract where exposure to toxicants in toad secretions is the greatest.
Sublingual or buccal absorption bypasses metabolism in the rest of the GI tract and first-pass hepatic metabolism, resulting in greater systemic exposure to unmetabolized bufadienolides. 22 While absorption from the oral cavity of the cardiac glycoside, ouabain, has been shown to occur in a canine ex vivo model and in humans, to the authors' knowledge there are no studies that provide evidence of oral absorption of other cardiac glycosides or bufadienolides. 22, 23 It has been theorized that vomiting of the swallowed secretions prevents significant GI absorption of the toxic constituents of the secretions. 24 Bufadienolides exert similar effects to cardiac glycosides by inhibiting the sodium, potassium-adenosine triphosphatase (Na 25 Pump inhibition results in intracellular sodium and calcium accumulation and potassium depletion, manifesting as increased excitability of cardiac Purkinje fibers and neurons. 13, 26, 27 Bufadienolides also affect voltage-gated sodium, potassium, and calcium channels, further destabilizing excitable membranes. 27 These changes ultimately lead to arrhythmias and CNS stimulation. 1, 28 Additionally, transcellular shifting of potassium out of the cell from inhibition of the Na 
Catecholamines
Catecholamines found in the secretions of R. marina include epinephrine, comprising at least 5% of the content of dried secretions, and much smaller amounts of norepinephrine and dopamine. 1 GI absorption of catecholamines is minimal due to the presence of inactivating enzymes in the GI mucosa. However, epinephrine is well absorbed sublingually, with an initial peak in the plasma occurring as early as 10 min post-administration. 33 While catecholamines alone can be arrhythmogenic, their ability to cause arrhythmias increases when combined with other arrhythmogenic compounds. 28 Otani et al. reported that the cardiac glycoside, ouabain, and epinephrine together better reproduced the cardio-respiratory effects of IV administration of R. marina toxins than either substance alone. 8 Additionally, the bufadienolide, bufalin, has been shown to increase the release and decrease the reuptake of norepinephrine, elevating synaptic norepinephrine concentrations, in a canine saphenous vein model. 34 These findings suggest that catecholamines and bufadienolides may act synergistically to produce the clinical effects of R. marina toad toxicosis.
Indolealkylamines
Indolealkylamines are compounds derived from serotonin. Dehydrobufotenine is the most common indolealkylamine found in R.
marina secretions. 14, 35 Daly et al. reported large amounts of dehydrobufotenine in the parotoid glands but did not quantify the amount. 36 Serotonin has also been isolated from R. marina secretions, but only in small amounts that comprise 0.1% of the content of dried secretions. 9 Because many indolealkylamines are polar compounds, they are limited in their ability to cross biologic membranes within the physiologic pH range. 37 This suggests that dehydrobufotenine is even more limited in the ability to traverse membranes because it is an ionized quaternary ammonium compound.
Although it is questionable whether indolealkylamines are absorbed to an extent sufficient to contribute to the toxicity of R. 
Decontamination
Oral lavage is the most important step in decontamination. Because it is vital to remove the toad's secretions from the oral cavity as soon as possible to limit continued absorption of the toxins, this should be performed by the owners at home if the patient is conscious and the exposure has just been witnessed. 2 The owner should be directed to lavage the mouth with water from a garden hose. The spray should be directed from the commissure of the mouth in a rostral direction and the patient's head should be facing down in order to avoid iatrogenic aspiration. If the patient is seizuring, oral lavage should be performed by the veterinarian using water-soaked gauze and airway protection as needed.
Although the efficacy of administering activated charcoal for R. marina toxicosis has not been evaluated, it has been shown to reduce absorption of bufadienolides in an in vivo rodent model. 47 However, administration of activated charcoal is not recommended in the typical exposure scenario because it is questionable whether a significant amount of secretions traverse distal to the oral cavity, and because administering activated charcoal to patients that are vomiting or displaying CNS signs is contraindicated. Activated charcoal may be more important if other forms of toad secretions, such as traditional Chinese medications, which contain dried secretions, or if whole toads are ingested. In the latter case, endoscopic or surgical removal, or multiple doses of activated charcoal, has been recommended. 13, 48 Cholestyramine can be used to treat cardiac glycoside toxicosis but has been shown to be inferior to activated charcoal in preventing absorption of digoxin, suggesting that it may be less efficacious than activated charcoal in treating R. marina toxicosis. secretions. Maropitant may be beneficial due to its action as a NK-1 receptor antagonist both centrally and locally in the GI tract. 50 The effectiveness of specific anti-emetics has not been evaluated for treating R. marina toxicosis.
Anticonvulsant Therapy
The benzodiazepines diazepam or midazolam can be used to control seizure activity. 2, 3, 43 In cases that are refractory to initial therapy with a benzodiazepine, a continuous propofol drip in combination with a benzodiazepine allows for intubation. 51 In cases the authors have 
Respiratory Therapy
Significant respiratory or ventilatory compromise may be present requiring oxygen supplementation or positive pressure ventilation, respectively. 43 Flow-by or nasal oxygen, or an oxygen chamber, should be provided as a conservative measure in the more stable patients. 52, 53 Patients should be monitored for the development of non-cardiogenic pulmonary edema and, when pre-existing occult heart disease is present, judicious use of fluid therapy and monitoring for cardiogenic pulmonary edema is important. 43 
Treating Electrolyte and Acid-Base Imbalances
Monitoring acid-base and electrolyte abnormalities will allow for early recognition and correction of any potentially life-threatening abnormalities, as well as assist in the diagnosis of occult shock.
Abnormalities, such as hyperkalemia and metabolic or respiratory acidosis, are best treated using standard therapeutic modalities for these conditions. 43 
Cardiovascular Therapy
No specific drugs are inherently more efficacious for antiarrhythmic therapy due to R. marina toxicosis so the choice of an anti-arrhythmic should be based upon the type of arrhythmia. 43 Magnesium levels should be evaluated and corrected as needed.
Parenteral magnesium may be beneficial, particularly in the management of ventricular arrhythmias, because hypomagnesemia potentiates the effects of cardiac glycosides. 54 Magnesium is required for normal functioning of the Na
so it is vital for maintaining the normal resting membrane potential of excitable membranes. 55 Magnesium also modulates the binding of cardiac glycosides to the Na The dose of digoxin Fab to administer to dogs is uncertain.
Digoxin Fab does not bind other cardiac glycosides as well as it does digoxin, so it is anticipated that higher doses of digoxin Fab are needed to treat R. marina toxicosis versus digoxin toxicosis. 59 In humans, 10 vials (38 mg/vial) are empirically recommended for toxicosis from ingestion of toad secretions. 48 
